Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
about
Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United kingdom.Metabolomics Analysis Reveals the Participation of Efflux Pumps and Ornithine in the Response of Pseudomonas putida DOT-T1E Cells to Challenge with PropranololRemoval of steroid estrogens from municipal wastewater in a pilot scale expanded granular sludge blanket reactor and anaerobic membrane bioreactorNeglected sources of pharmaceuticals in river water--footprints of a Reggae festival.Global synthesis and critical evaluation of pharmaceutical data sets collected from river systemsRanking prescribed pharmaceuticals in terms of environmental risk: Inclusion of hospital data and the importance of regular review.Temporal variability of antibiotics fluxes in wastewater and contribution from hospitals.Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment.Toxicokinetic Triage for Environmental Chemicals.Seasonal Monitoring of Cardiovascular and Antiulcer Agents' Concentrations in Stream Waters Encompassing a Capital City.Biodegradability of fluoxetine, mefenamic acid, and metoprolol using different microbial consortiums.Impact of anti-inflammatories, beta-blockers and antibiotics on leaf litter breakdown in freshwaters.Risk-based prioritization of pharmaceuticals in the natural environment in Iraq.Treatment and removal strategies for estrogens from wastewater.Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish.The potential and promise of mefenamic acid.The potential environmental risks of pharmaceuticals in Vietnamese aquatic systems: case study of antibiotics and synthetic hormones.Ecotoxicological risk assessment and seasonal variation of some pharmaceuticals and personal care products in the sewage treatment plant and surface water bodies (lakes).Simultaneous extraction and concentration of water pollution tracers using ionic-liquid-based systems.Risk estimation and annual fluxes of emerging contaminants from a Scottish priority catchment to the estuary and North Sea.Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose?Photolysis of pharmaceuticals and personal care products in the marine environment under simulated sunlight conditions: irradiation and identification.Application of chemometrics in understanding the spatial distribution of human pharmaceuticals in surface water.Toxicity of individual pharmaceuticals and their mixtures to Aliivibrio fischeri: Experimental results for single compounds and considerations of their mechanisms of action and potential acute effects on aquatic organisms.Monitoring the effects of chiral pharmaceuticals on aquatic microorganisms by metabolic fingerprinting.Bioconcentration of two basic pharmaceuticals, verapamil and clozapine, in fish.Systematic screening of common wastewater-marking pharmaceuticals in urban aquatic environments: implications for environmental risk control.Occurrence of non-steroidal anti-inflammatory drugs in Tehran source water, municipal and hospital wastewaters, and their ecotoxicological risk assessment.Pharmaceutical concentrations in screened municipal wastewaters in Victoria, British Columbia: A comparison with prescription rates and predicted concentrations.A rational approach to selecting and ranking some pharmaceuticals of concern for the aquatic environment and their relative importance compared with other chemicals.Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment.Advanced photochemical oxidation of emergent micropollutants: carbamazepine.Occurrence and behavior of the chiral anti-inflammatory drug naproxen in an aquatic environment.Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland.Ecotoxicity of raw and treated effluents generated by a veterinary pharmaceutical company: a comparison of the sensitivities of different standardized tests.Phototransformation of mefenamic acid induced by nitrite ions in water: mechanism, toxicity, and degradation pathways.Adsorption of the antiepileptic carbamazepine onto agricultural soils.Occurrence of antibiotics as emerging contaminant substances in aquatic environment.Occurrence and removal of emerging pharmaceutical, personal care compounds and caffeine tracer in municipal sewage treatment plant in Western Greece.Consumption-based approach for predicting environmental risk in Greece due to the presence of antimicrobials in domestic wastewater.
P2860
Q24811702-33F08487-17BE-4CEF-98FB-3F8118FFE1ECQ28552021-7BD428EF-4C94-44FB-B7B6-168EC3187CE9Q30370946-CE7B29D3-AAB5-41D1-8D08-B8D5D840FF49Q30557322-EF4A028C-6672-420C-91BF-5310DB64D991Q30580997-4ECB0DB2-6AB9-416B-9D92-A4D2722F992AQ31020572-4FBA9D87-80D9-439B-930B-F8A9FBDEB621Q34548303-389FA548-55A2-43CF-A423-F193647500C0Q35870888-74F67EB7-50ED-4F35-ACEC-A8047A431AA4Q36027800-BA85BEAA-ECB0-434C-9AFF-463FDCEC09E9Q36129550-93BFA7D6-6181-4F22-BD06-16507600F9EAQ36250513-957E07F7-DA1B-4CCE-B58D-5B03C2D33A19Q36534466-07381632-CAA5-4C54-A9D9-8B55397DA858Q37116450-70457E92-CA6B-4164-B7CF-F7E0B4BED39CQ37210383-43C2BD57-262B-409C-B6AA-CFF34E899C0BQ37708300-436B72B6-6237-4221-8032-450CAEFA4D3FQ38105148-CEAF232D-CED6-43D6-A1B6-C4D879557109Q38128738-C1625C27-76BF-4999-9BBA-B5AC249AA737Q38629380-44D18AFA-4F08-4176-93F2-A29F65C03DACQ38631803-4867F3DC-8CC3-4C59-A9A3-0972CC3C68EBQ38703286-47DFE50C-6019-4D9E-8E9E-C1A5D20D8E2CQ38801022-96EDA624-DE6A-4774-AE98-563C38954733Q38813403-0551EEDB-3420-4268-AEB0-276CEBA63098Q38866449-0F18C927-DD4E-4FAD-B11F-3E8179524B1DQ39551141-21B06B49-9EC3-44DB-BFA4-EE427057E1DAQ39892404-AA04935C-1167-48C0-8CA6-C24647A4B2EEQ40121436-C5AA474B-575E-4D15-AF6A-1F5914FD8CF0Q40172613-0FE93B48-9A73-4730-B1EF-D65F8C3F92E9Q40329248-5F381251-A7E0-4DDC-8C72-EADA97D20A48Q40546346-EBFD6280-7B8B-4C59-96C6-BC04A3BC750DQ40726531-16155134-DA1E-4B00-B10D-F92E2130502EQ43191450-D2E9B273-742B-49E1-A6CC-2936D4AA6B6EQ43317141-C5008840-9EDD-429D-B9CE-745884B32EE0Q43323357-6449ADCB-406D-4644-8E09-47D52815E050Q43328441-12FFC90C-8758-4A76-B7BF-397833EBA211Q43329439-1771556D-DAC4-4440-BA41-7799D73BEFFDQ43332422-73DB53A8-412B-4643-AD22-975C4CCD3715Q43343436-736B8F7E-1386-4E6E-B7E3-45C79DA0E36AQ43350601-5B147894-F0C7-4BA9-A656-1F1AED88ECFEQ43358910-AC589B95-4914-4385-84B9-91B6C599F261Q43577039-BB8CA620-EA42-44E9-A96D-2C70554406CD
P2860
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@en
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@nl
type
label
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@en
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@nl
prefLabel
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@en
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.
@nl
P1433
P1476
Aquatic environmental assessment of the top 25 English prescription pharmaceuticals
@en
P2093
J N Lester
P304
P356
10.1016/S0043-1354(02)00227-0
P407
P577
2002-12-01T00:00:00Z